Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi. Umeå universitet, Medicinska fakulteten, Institutionen för epidemiologi och global hälsa.ORCID-id: 0000-0003-2517-6881
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID-id: 0000-0001-6808-4405
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0002-2974-2003
Visa övriga samt affilieringar
2022 (Engelska)Ingår i: Journal of the National Cancer Institute, ISSN 0027-8874, E-ISSN 1460-2105, Vol. 114, nr 1, s. 38-46Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BACKGROUND: Antibiotics use may increase colorectal cancer (CRC) risk by altering the gut microbiota, with suggestive evidence reported. Our study aims to investigate antibiotics use in relation to subsequent CRC risk.

METHODS: This is a nationwide, population-based study with a matched case-control design (first primary CRC cases and 5 matched, cancer-free controls). Complete-population data, extracted from Swedish national registers for the period 2005-2016, were used to calculate odds ratios and 95% confidence intervals.

RESULTS: We included 40 545 CRC cases and 202 720 controls. Using the full dataset, we found a positive association between more frequent antibiotics use and CRC, excluding antibiotics prescribed within 2 years of diagnosis attenuated results toward the null. In site-specific analyses, excluding the 2-year washout, the positive association was confined to the proximal colon (adjusted odds ratio for very high use vs no use = 1.17, 95% confidence interval = 1.05 to 1.31). For rectal cancer, an inverse association, which appears to be driven by women, was observed. Quinolones and sulfonamides and/or trimethoprims were positively associated with proximal colon cancer, whereas a more general inverse association, across antibiotics classes, was observed for rectal cancer. We found no association between methenamine hippurate, a urinary tract antiseptic not affecting the gut microbiota, and CRC risk.

CONCLUSIONS: This register-based study covering the entire population of Sweden found a robust association between antibiotics use and higher risk of proximal colon cancer and an inverse association with rectal cancer in women. This study strengthens the evidence from previous investigations and adds important insight into site-specific colorectal carcinogenesis.

Ort, förlag, år, upplaga, sidor
Oxford University Press, 2022. Vol. 114, nr 1, s. 38-46
Nationell ämneskategori
Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
Forskningsämne
epidemiologi
Identifikatorer
URN: urn:nbn:se:umu:diva-188711DOI: 10.1093/jnci/djab125ISI: 000748167200010PubMedID: 34467395Scopus ID: 2-s2.0-85123649937OAI: oai:DiVA.org:umu-188711DiVA, id: diva2:1604376
Forskningsfinansiär
Region Västerbotten, RV 932777Tillgänglig från: 2021-10-19 Skapad: 2021-10-19 Senast uppdaterad: 2024-02-20Bibliografiskt granskad
Ingår i avhandling
1. Antibiotics use in relation to colorectal cancer risk, survival and postoperative complications
Öppna denna publikation i ny flik eller fönster >>Antibiotics use in relation to colorectal cancer risk, survival and postoperative complications
2024 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Background: Growing evidence suggests that antibiotic-induced dysbiosis of gut microbiota potentially contributes to colorectal cancer development and oncological outcomes. However, the role of antibiotics in colorectal cancer incidence, survival and postoperative outcomes at a population level remains incompletely understood.

Aims: The overall aim of the thesis is to investigate prescription antibiotics use in relation to colorectal cancer risk, survival and postoperative complications, particularly surgical site infections including anastomotic leakage.

Methods: The thesis work includes matched case-control and cohort studies, leveraging complete population-based data from Swedish national registers. Paper I is a matched case-control study that consists of 40 545 colorectal cancer cases and 202 720 matched controls, aiming to investigate antibiotics use and risk of incident colorectal cancer. Multivariable conditional logistic regression was used. Paper II is a cohort study, including 47 303 colorectal cancer cases, investigating antibiotics use in relation to cancer-specific survival. Stratified Cox proportional-hazards regression was used. Paper III includes 38 839 colorectal cancer cases who had undergone abdominal tumour-resection surgery and assesses antibiotics use in relation to surgical site infections, including anastomotic leakage, within 30 days after surgery. Logistic regression with multi-level mixed-effects models was used.

Results: In paper I, a dose-response association between antibiotics use and a higher risk of proximal colon cancer was found, whereas a slight inverse association with rectal cancer was observed, mainly in women. A null association was found between methenamine hippurate, assessed as a negative control due to no known effect on gut microbiome, and the risk of colorectal cancer. In paper II, the findings did not support any substantial negative effect of antibiotics on cancer-specific survival, except for very high cumulative exposure (>180 days) in stage I-III diseases. In stage IV colorectal cancer, modest inverse relationships between antibiotics use and survival were noted. In paper III, prescription antibiotics use up to 4.5 years before surgery was associated with a higher risk of surgical site infections, including anastomotic leakage, after colon cancer surgery but not rectal cancer surgery. A null association was observed between methanamine hippurate and the risk of surgical site infections. For cardiovascular and/or neurological complications, also considered as a negative control due to expected negligible or null effects of gut microbiome on these outcomes after surgery, associations were null in both colon and rectal cancer.

Conclusion: These studies provided further support for antibiotics use as a modifiable risk factor for proximal colon cancer and identified antibiotics taken long before surgery as a novel risk factor for surgical site infections, including anastomotic leakage, after colon cancer surgery. In contrast, we did not find any substantial negative impact of antibiotics on cancer-specific survival. Taken together, the findings described in this thesis provide etiological insights and may contribute to strategies to prevent colon cancer and improve postoperative outcomes through prudent use of antibiotics, thereby aiding in the reduction of colorectal cancer incidence and mortality.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University, 2024. s. 64
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2282
Nyckelord
colorectal cancer, antibiotics, gut microbiome, dysbiosis, cancer-specific survival, surgical site infections, anastomotic leakage, register-based epidemiology
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
cancerepidemiologi; cancerepidemiologi; onkologi; kirurgi
Identifikatorer
urn:nbn:se:umu:diva-221316 (URN)978-91-8070-270-6 (ISBN)978-91-8070-271-3 (ISBN)
Disputation
2024-03-22, Hörsal Betula, 6M Building, Umeå University Hospital, Umeå, 13:00 (Engelska)
Opponent
Handledare
Tillgänglig från: 2024-03-01 Skapad: 2024-02-20 Senast uppdaterad: 2024-02-21Bibliografiskt granskad

Open Access i DiVA

fulltext(1189 kB)153 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 1189 kBChecksumma SHA-512
2b2d5ac168bcf22d29ad5af4529cda8cd25febcbbd9edf3305f462c039729cb3831f76c82b7c6f3eca8880d9db52989a54e3a91ab5e61aba0c81f1e671e963c0
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Lu, Sai San MoonHäggström, ChristelMyte, RobinLindquist, ElisabethGylfe, Åsavan Guelpen, BethanyHarlid, Sophia

Sök vidare i DiVA

Av författaren/redaktören
Lu, Sai San MoonHäggström, ChristelMyte, RobinLindquist, ElisabethGylfe, Åsavan Guelpen, BethanyHarlid, Sophia
Av organisationen
OnkologiInstitutionen för epidemiologi och global hälsaInstitutionen för molekylärbiologi (Medicinska fakulteten)Institutionen för klinisk mikrobiologiMolekylär Infektionsmedicin, Sverige (MIMS)Umeå Centre for Microbial Research (UCMR)Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
I samma tidskrift
Journal of the National Cancer Institute
Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 214 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 568 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf